Company / Operating Cash Flow per Share
Vera Therapeutics, Inc. Operating Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$3.75
FY2025
5-year range
-$3.75 / -$1.76
FY2021-FY2025
Trend
-54.2%
vs FY2024
Sector context
#182 of 212
Health Care
What the data says
Vera Therapeutics, Inc.'s operating cash flow per share of $-3.75 is lower than 86% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share has fluctuated over the past 6 years, ranging from $-108.79 in FY2020 to $-1.76 in FY2021.
Based on SEC 10-K filings.
-3.75 in FY2025.
Declined from $-2.16 to $-3.75 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
+74.5% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 54.2% year-over-year.
- Ranks #182 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2021.
- Lowest operating cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.75 | -54.2% |
| FY2024 | -$2.43 | -12.8% |
| FY2023 | -$2.16 | +15.2% |
| FY2022 | -$2.54 | -44.2% |
| FY2021 | -$1.76 | +98.4% |
| FY2020 | -$108.79 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026